Patent · US Expired

Peptidyl compounds

US6048841A · kind A · utility

18Cited by

2References

17Claims

0Family size

Assignee

Darwin Discovery Limited · GB

Inventors

Andrew Douglas Baxter · Cambridge, GB
John Gary Montana · Harlow, GB

Key dates

Filing date	Nov 22, 1996
Grant date	Apr 11, 2000
Priority date	—
Expiry date	Nov 22, 2016

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/868
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Peptidyl compounds having an imidazole substituent have therapeutic utility via their inhibitory effect on metalloproteinases and tumour necrosis factor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.